Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

BACKGROUND: Invasive candidiasis and/or candidemia (IC/C) is a common fungal infection leading to significant health and economic losses worldwide. Caspofungin was shown to be more effective than fluconazole in treating inpatients with IC/C. However, cost-effectiveness of caspofungin for treating IC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebretekle, Gebremedhin Beedemariam, Fentie, Atalay Mulu, Gebremariam, Girma Tekle, Ali, Eskinder Eshetu, Erku, Daniel Asfaw, Alemayehu, Tinsae, Abebe, Workeabeba, Sander, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618213/
https://www.ncbi.nlm.nih.gov/pubmed/36309674
http://dx.doi.org/10.1186/s12913-022-08662-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618213/
https://www.ncbi.nlm.nih.gov/pubmed/36309674
http://dx.doi.org/10.1186/s12913-022-08662-3

Ejemplares similares